THREONINE

Molecular Excipient

Mwt. LogP HBD HBA PSA RB CSP3
119.0 -1.2 3 3 84.0 2 0.75
CAS
72195
UNII
2ZD004190S
SYNONYMS
ZINC ID(s)
Availability
Present in 96 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
Code Date Title Phase Status
NCT02364843 2015-03-01 A Physiological Study to Determine How Much Threonine Infants Ages 1 - 6 Months Require in Their Diets Phase 0 Not Yet Recruiting
NCT01032616 2009-12-01 Uptake and Utilization of Amino Acids by Splanchnic Bed Phase 1 Completed

(Browse) Purchasable Analogs in ZINC

Dosages

Route Formulation Per Unit Dose
Intravenous Powder, For Injection Solution, Lyophilized 16%
Iv(infusion) Injection 45%
Iv(infusion) Solution, Injection 0.12%

More Information

Usage Over Time

Comments